The Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. From Wikipedia
An October trial date will determine if AstraZeneca failed to disclose a known mesenteric thrombosis risk when its Covid-19 vaccine was approved.
